Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial

BACKGROUND: Whereas lowering the intraocular pressure (IOP) can slow optic nerve degeneration in glaucoma, many patients with glaucoma continue to develop progressive loss in vision despite a significant reduction in IOP. No treatment has been shown to be effective for neuroprotection in glaucoma. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Christopher Kai Shun, Ren, Seraph Tianmin, Chan, Poemen Pui Man, Wan, Kelvin Ho Nam, Kam, Aziz Ka Wai, Lai, Gilda Wing Ki, Chiu, Vivian Sheung Man, Ko, Match Wai Lun, Yiu, Cedric Ka Fai, Yu, Marco Chak Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762963/
https://www.ncbi.nlm.nih.gov/pubmed/35039056
http://dx.doi.org/10.1186/s13063-021-05968-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762963/
https://www.ncbi.nlm.nih.gov/pubmed/35039056
http://dx.doi.org/10.1186/s13063-021-05968-1

Ejemplares similares